MenterA, StroberBE, KaplanDH, et al.Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019; 80(4):1029–1072; doi: 10.1016/j.jaad.2018.11.057
2.
Al-JanabiA, FoulkesAC, GriffithsCEM, et al.Paradoxical eczema in patients with psoriasis receiving biologics: A case series. Clin Exp Dermatol. 2022; 47(6):1174–1178; doi: 10.1111/ced.15130
3.
YuS, LiY, ZhouY, et al.Immune mediators and therapies for pruritus in atopic dermatitis and psoriasis. J Cutaneous Imm & Allergy. 2019; 2(1):4–14; doi: 10.1002/cia2.12049
4.
Al-JanabiA, AlabasOA, YiuZZN, et al.; BADBIR Study Group. Risk of paradoxical eczema in patients receiving biologics for psoriasis. JAMA Dermatol. 2024; 160(1):71–79; doi: 10.1001/jamadermatol.2023.4846
5.
CunliffeA, GranS, AliU, et al.Can atopic eczema and psoriasis coexist? A systematic review and meta-analysis. Skin Health Dis. 2021; 1(2):e29; doi: 10.1002/ski2.29
